Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)Domenico Russo, Anna Paola Iori, Massimo Martino et al.|Bone Marrow Transplantation|2021Cited by 20
First results of the Phase III GIMEMA ALL2820 trial comparing ponatinib plus blinatumomab to imatinib and chemotherapy for newly diagnosed adult ph+ acute lymphoblastic leukemia patientsSabina Chiaretti, Paola Fazi, Mariangela Di Trani et al.|Blood|2025Cited by 12
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Domenico Russo, Nicola Polverelli et al.|Transplantation Direct|2023Cited by 10
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeMirko Farina, Domenico Russo, Maria Chiara Scaini et al.|Transplantation and Cellular Therapy|2024Cited by 9